Physician profile
Christopher Smitson
NPI 1174865760
$24,118.44
in general payments reported to CMS, 2019-2025
17 companies · $437 in 2025
The $437 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $305 · 2021: $1,170 · 2022: $1,557 · 2023: $1,528 · 2024: $203 · 2025: $437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,605 · Travel and Lodging: $562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,605.30 |
| Travel and Lodging | $562.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $18,271.83 | 2019-2020 | |
| Edwards Lifesciences Corporation | $3,144.23 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Abiomed | $511.61 | 2019-2021 | |
| Abbott Laboratories | $457.29 | 2019-2024 | Ensite, Cardiomems |
| Shockwave Medical, INC | $319.16 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Chiesi USA, INC. | $275.95 | 2019-2020 | |
| Endologix LLC | $201.25 | 2023 | Endocross Device, Torus Stent Graft System |
| Terumo Medical Corporation | $160.52 | 2019-2021 | |
| Medtronic, INC. | $159.91 | 2022 | |
| Stryker Corporation | $129.56 | 2023-2025 | Artix Mt, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Surmodics, INC. | $120.13 | 2024-2025 | Sublime Microcatheter, 018, 200cm, Straight, Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $102.75 | 2019-2023 | Lifevest |
| Biotronik INC. | $89.06 | 2019-2021 | |
| Heartflow, INC. | $86.24 | 2022 | |
| Janssen Pharmaceuticals, INC | $58.01 | 2021-2023 | Xarelto |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $15.76 | 2022 | |
| Cardiovascular Systems INC. | $15.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Smitson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.